Inogen | INGN - Należności Handlowe





Należności Handlowe Zmiana Data
Abbott USD 10.57B 171M 2025-12
Accuray USD 91.79M 7.07M 2024-09
AngioDynamics USD 44.43M 1.79M 2025-09
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 71.31M 4.66M 2026-03
Baxter International USD 1.7B 310M 2026-03
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Boston Scientific USD 2.93B 98M 2025-12
Chart Industries USD 1.77B 25.5M 2025-12
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.09B 182.1M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Globus Medical USD 743.66M 55.54M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 516.9M 54.7M 2025-12
Masimo USD 391.9M 36M 2025-12
Medtronic USD 6.36B 30M 2025-12
Orthofix International USD 135.75M 4.94M 2025-12
Philips EUR 3.8B 266M 2025-12
ResMed USD 998.84M 13.2M 2026-03
Steris USD 990.6M 43.3M 2025-12
Stryker USD 3.57B 468M 2026-03
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 345.58M 247.07M 2025-12
X T L Biopharmaceuticals USD 90K 9K 2025-06
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03